'Cnv' presentation slideshows

A GLMM-based Collapsing Method for Rare CNV Analysis

1. Jung-Ying Tzeng Bioinformatics Research Center & Department of Statistics NC State University Joint work with Jin Szatkiewicz and Patrick Sullivan @ UNC-CH. A GLMM-based Collapsing Method for Rare CNV Analysis. ENAR March 18, 2014. 2. Copy Number Variants (CNVs).

626 views • 49 slides

Age- related macular degeneration

Age- related macular degeneration. Age-related macular degeneration (AMD). The most common cause of blindness in developped countries. Age-related macular degeneration (AMD). AMD is multifactorial disease caused by combination of predisponing genes and influences of external environment.

368 views • 32 slides

Automating NGS Gene Panel Analysis Workflows

Automating NGS Gene Panel Analysis Workflows. Gabe Rudy, VP of Product & Engineering. 20 Most Promising Biotech Technology Providers. Hype Cycle for Life sciences. Top 10 Analytics Solution Providers. NIH Grant Funding Acknowledgments.

283 views • 26 slides

COST B27 Working Group 3 MK national report

COST B27 Working Group 3 MK national report. Georgi Stojanov Faculty of Electrical Engineering University of SS Cyril and Methodius in Skopje, Macedonia. TALK OUTLINE. PREVIOUS EXPERIENCE CNV and DCNV extraction and recognition EEG controlled devices ONGOING RESEARCH

397 views • 25 slides

AGE-RELATED MACULAR DEGENERATION (AMD)

AGE-RELATED MACULAR DEGENERATION (AMD). 1. Drusen. 2. Drusen and AMD. 3. Atrophic AMD. 4. Exudative AMD. Pigment epithelial detachment (PED). Choroidal neovascularization (CNV). Drusen. Histopathology. Hard. Soft. Larger, ill-defined spots. Small well-defined spots.

407 views • 18 slides

Corporate Technology Ventures

Corporate Technology Ventures. Types of Business Ventures. Small business Sole proprietor, partnership, < 30 employees, $3million Niche business High-growth business Radical innovation business Corporate new venture. Corporate New Venture. CNV or Intrapreneurship Characteristics

331 views • 12 slides

COMPARATIVE LONG TERM RESULTS OF THREE DIFFERENT THERAPIES FOR MYOPIC CHOROIDAL NEOVASCULARIZATION

COMPARATIVE LONG TERM RESULTS OF THREE DIFFERENT THERAPIES FOR MYOPIC CHOROIDAL NEOVASCULARIZATION. J.A. Montero, J.M. Ruiz-Moreno VISSUM, Alicante Institute of Ophthalmology, Vitreo-Retina Unit, Alicante Pio del Rio Hortega University Hospital, Ophthalmology Unit, Valladolid

104 views • 9 slides

Obviously, racially demarcated voter Disenfranchisement is a remnant of the Past?

132 views • 5 slides